Dr. Susan Buchbinder highlights the reports on curbing transmission of HIV, from the 15th Conference on Retroviruses and Opportunistic Infections. Medscape HIV/AIDS
Among HIV-infected patients initiating antiretroviral therapy, there are significant differences in specific adverse events by gender and race but not in the overall rate of adverse events, death from any cause, or rates of toxicity-related treatment withdrawal, new research indicates. Reuters Health Information
Dr. Susan Buchbinder discusses the data on HIV vaccine prevention studies presented at the 15th Conference on Retroviruses and Opportunistic Infections. Medscape HIV/AIDS
An emtricitabine-based antiretroviral regimen is safe and effective in pediatric patients infected with HIV, according to a report in the April issue of Pediatrics. Reuters Health Information
The results of a pharmacokinetic study in HIV-seronegative volunteers identified "unexpected and statistically significant" increases in rosuvastatin (Crestor) plasma concentrations when co-administered with the combination of lopinavir/ritonavir (Kaletra), a researcher involved in the study told Reuters Health. Reuters Health Information
Since free antiretroviral therapy was offered to more than 80,000 HIV-infected adults in Malawi a few years ago, mortality has fallen by up to 35%, according to a report in the May 10th issue of The Lancet. Reuters Health Information
The dyslipidemia associated with HIV is common and is attributed to HIV itself and/or the antiretroviral therapy used to treat HIV. What will the updated guidelines suggest to help these patients? Future Lipidology
Rapid oral-fluid testing for HIV, counseling, and mother-to-child transmission (MTCT) prophylaxis in all women at the time of delivery are feasible and cost-effective in resource-poor settings, according to the results of a study from India. Reuters Health Information
